The US has given the go-ahead for the country’s largest steel producer to seek a ban on imports from Chinese rivals, in the first known case in which trade sanctions could be used in retaliation for alleged China government-backed hacking of commercial secrets.
The move comes ahead of a meeting of senior US and Chinese officials in Beijing next week. It highlights the increasingly aggressive tactics the US steel industry is using to fight back against the flood of cheap Chinese steel that has hit global markets in recent years, as well as the growing international concerns about industrial overcapacity in China.
Depending on the outcome the development could eventually result in the next president authorising a blanket ban on imports of Chinese steel in retaliation for the alleged hacking.
“Trade disputes between China and The US should be addressed in accordance with World Trade Organisation principles,” Zhu Guangyao, China’s vice-finance minister, said at a briefing in Beijing on Thursday. “We are opposed to abusive trade remedy measures.”
US Steel in late April filed the case under the US’s “Section 337” rule, which allows trade sanctions for intellectual property theft. It alleged that some four dozen Chinese companies and their US subsidiaries had both acted as a cartel and benefited from the cyber theft of its production secrets.
Full Content: Times Live
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas